(MedPage Today) -- Adding the endothelin receptor antagonist atrasentan to renin-angiotensin blockade reduced albuminuria without major side effects in patients with diabetic nephropathy, researchers found.
Siemens Healthcare and the National Kidney Foundation (NKF) announced
today a new strategic alliance focusing on education, awareness and
screening for kidney disease in high-risk individuals. This important
Keryx Biopharmaceuticals, Inc.
(Nasdaq: KERX) (the "Company") today announced that Phase 2 clinical results of
Zerenex™ (ferric citrate coordination complex) in non-dialysis dependent
chronic kidney disease (NDD-CKD) patients with elevated serum...
AstraZeneca has struck up a partnership with the Shenzhen University Health Science Center in Shanghai to collaborate on preclinical work for chronic kidney disease treatments, a growing problem among China's aging population.
ALEXANDRIA, VA -- (Marketwired) -- 03/24/14 --
The American Diabetes Association (Association) is pleased to announce The American Diabetes Association and Boehringer Ingelheim Research Award: Chronic Kidney Disease and Renal Insufficiency...
By Don Dion:
Akebia Therapeutics Inc. (AKBA), a biopharmaceutical firm, focused on the development of novel treatments for anemia, plans to raise $76.0 million in its upcoming IPO.
The Cambridge, Massachusetts-based firm will offer 4.9 million...
Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company” or “La
Jolla”) today announced positive top-line results from its randomized,
placebo-controlled Phase 2 trial of GCS-100 in chronic kidney disease
(MedPage Today) -- Among patients with atrial fibrillation and a recent heart attack, warfarin use was associated with improved outcomes -- without excess bleeding -- regardless of the level of kidney function, a Swedish study showed.
Oops! Unable to complete your request. Please refresh your browser.